Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
1.750
-0.070 (-3.85%)
At close: Nov 19, 2025, 4:00 PM EST
1.680
-0.070 (-4.00%)
After-hours: Nov 19, 2025, 7:01 PM EST

Estrella Immunopharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '25 Dec '24 Jun '24 Jun '23 Jun '22 Jun '21
66433819--
Market Cap Growth
133.37%13.67%101.23%---
Enterprise Value
64423321--
Last Close Price
1.751.201.0510.8410.00-
PB Ratio
-302.068.94-2.81--
P/TBV Ratio
-302.068.94---
Debt / Equity Ratio
00.030.000.00--
Quick Ratio
0.120.3123.050.254.32-
Current Ratio
0.150.5524.650.285.20-
Return on Assets (ROA)
---122.12%-174.75%--
Return on Capital Employed (ROCE)
137.30%-6160.10%-171.10%165.20%-42.40%-
Earnings Yield
-20.44%-20.39%-19.14%-58.56%--
Buyback Yield / Dilution
-2.36%-34.73%-8764.81%---
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q